@misc{indiciae6a326bea90e7,
  title = {Preclinical characterization of mobocertinib highlights the putative therapeutic window of this novel EGFR inhibitor to EGFR exon 20 insertion mutations},
  author = {Vasconcelos, P. E. N. S. and Kobayashi, I. S. and Kobayashi, S. S. and Costa, D. B.},
  year = {2020},
  doi = {10.1101/2020.09.28.317560},
  url = {https://www.biorxiv.org/content/10.1101/2020.09.28.317560v1},
  note = {Source identifier: 10.1101/2020.09.28.317560}
}